Top Data Analytics Companies (2,344)

Strong Revenue Growth: Revenue is growing at double-digit rates, with Q2 2026 up 27% year over year and first-half 2026 up about 25%. Management also raised full-year 2026 guidance to $94–96 million, implying approximately 22–24% growth.

Market Expansion: U.S. activity accelerated, with U.S. analysis volume up 60% year over year in Q2 2026 and major health-system additions. Core genomics customers increased to 542 as of June 30, 2026, from 490 a year earlier.

Customer Loyalty & Retention: Net dollar retention improved to 117% in Q2 2026 (versus 107% a year earlier), indicating greater spending within the installed base. Platform usage also reached a record 115,000 analyses in Q2 2026, up 22% year over year.

Investor Backing & Capital Strength: A majority investment by Nordic Capital and a $125 million financing from Vista Credit Partners are described as fueling accelerated innovation and scale. These developments signal ample capital access to support ongoing expansion.

Product Line Growth: The CareJourney acquisition and subsequent launches of expanded suites (e.g., Ascent, CareJourney, LifeScience) and AI-enabled capabilities broaden the platform’s functionality. These moves indicate a deliberate build-out of offerings across providers, payers, and life sciences.

Market Expansion: New customer business reportedly added more than 2.25 million value-based lives and brought the ecosystem to over 170 million patient records, with the combined portfolio approaching 200 organizations. Active customer and partner engagement at Aggregate 2025 further suggests a deepening commercial footprint.

Investor Backing & Capital Strength: The company secured a $135 million Series D in 2022, bringing total funding to $236 million and a reported billion-plus valuation. This capital base supports continued investment in product and market initiatives.

Strong Market Position & Advantage: The company reports more than 400 enterprise customers, including PepsiCo, Cisco, Nasdaq, Roche, and The New York Times. This breadth points to meaningful enterprise adoption and commercial scale.

Product Line Growth: The platform has expanded from data observability into AI reliability and agent observability, monitoring AI agents in production alongside underlying data pipelines. Company-reported usage metrics—such as 10 million tables monitored and 1,000 incidents resolved daily—indicate a growing product footprint.

Strong Revenue Growth: Financial results are reported as materially stronger in 2025, with total revenue and clearing-fee revenue significantly higher and operating income turning positive. Audited statements also show net income well above the prior year.

Market Expansion: The clearing footprint expanded with new participant venues such as IEX Options and MX2 Options, bringing coverage to 20 options exchanges plus two futures exchanges and one stock-loan exchange. The network also deepened with additions like State Street as a clearing member for the Stock Loan Program.

Resilient & Sustainable Growth: Cleared contract activity set records in 2025 and remained elevated through the first nine months of 2026, with notable strength across equity, ETF, and index options. Monthly data indicate the higher activity persisted into 2026 despite normal variability by product.

Innovation-Driven Growth: New AI agent-oriented products and data offerings were launched in 2026, including a MapQuest Model Context Protocol server, Dogpile Fetch, and the IntentStream audience-intent platform. These initiatives indicate efforts to expand beyond traditional advertising into AI-enabled distribution and data monetization.

Product Line Growth: Owned products show momentum, with Startpage sessions up 31% year over year in Q2 2026 (mobile app +63%) and MapQuest reporting 14% organic traffic growth and 23% site-wide revenue growth in Q1 2026. Segment data also show Products revenue rising 16% to $93.2 million in 2025.

Cost & Operational Efficiency: Margins improved as lower-margin search monetization was deliberately reduced, with adjusted gross margin reaching 85% in Q2 2026. Full-year 2025 also saw adjusted EBITDA increase 9% despite lower revenue, signaling a higher-quality revenue mix.

Strong Revenue Growth: Revenue has accelerated, with fiscal Q2 2027 rising 30% year over year to $771.8M after fiscal 2026 grew 23% to $2.46B. Management also raised fiscal 2027 revenue guidance to about $2.99–$3.03B.

Customer Loyalty & Retention: Existing customers are expanding spend, as net revenue retention reached 122% and customers generating at least $100,000 in ARR grew to nearly 3,000. Total customers also increased to roughly 70,600, indicating broadening adoption alongside expansion within accounts.

Healthy Cash Flow: Free cash flow nearly doubled to $137.6M in Q2 FY2027, alongside an improved non-GAAP operating margin of 24% and a swing to positive GAAP net income. Reported cash and short-term investments were approximately $2.4B at quarter-end.

Investor Backing & Capital Strength: Capital raising includes a $372 million Series D in 2024 with participation from Sanofi, bringing total funding above $600 million. The stated use of proceeds was to expand the drug pipeline and AI platform, indicating a strong financial base for growth.

Product Line Growth: The portfolio has expanded through multiple in-licensing deals in 2025–2026 and now spans preclinical, Phase 1, and Phase 2 programs. Tangible execution includes dosing the first participant in the BLKR201 Phase 1 trial in June 2026, only months after licensing the asset.

Strategic Partnerships: High-profile collaborations include work with Sanofi and OpenAI to build AI tools for drug development, alongside a Sanofi licensing agreement for gusacitinib with significant potential milestone value. These relationships reinforce external validation and create pathways to scale development.

Profitability: Operating earnings and margins improved notably in 2026, with Q3 operating earnings up sharply year over year and the operating margin rising to 5.6%. Feedback suggests earnings resilience is being supported by operational changes and a shifting business mix.

Strong Revenue Growth: Reported annual revenue expanded from $226.6B in 2023 to $270.6B in 2025, including roughly 12% growth in 2024 and 7% in 2025. This establishes a robust multi‑year revenue trajectory even as recent growth rates have moderated.

Cost & Operational Efficiency: Cost controls and operational improvements are described as lifting earnings despite lower revenue in 2026. Optum Health’s operating earnings rose from $41M to $735M year over year while serving fewer value‑based patients, indicating stronger execution.

Market Expansion: Contract expansions from an initial multi‑year agreement to a much larger five‑year ceiling and a separate five‑year Army award point to broader deployment across additional Army formations and regions. Announced work in Europe and Indo‑Pacific missions signals widening geographic reach within defense.

Investor Backing & Capital Strength: A March 2026 growth investment led by Washington Harbour Partners was designated to expand engineering, R&D, and delivery capacity. This capital indicates strengthened ability to scale to rising demand in government programs.

Strong Market Position & Advantage: Selection to support the Army’s Next Generation Command and Control efforts and rapid utilization of an initial contract ceiling indicate rising strategic relevance in defense AI operations. Independent defense reporting also corroborates the expansion of its enterprise agreement to a much larger capacity.

Investor Backing & Capital Strength: Investor backing is described as substantial, with the company reporting more than $60M raised and named support from NEA and Bain Capital; CB Insights also records a $45M Series A in 2023. This capital base provides resources to expand products and go-to-market even though it is not a proxy for revenue.

Product Line Growth: The portfolio has expanded from data compression and privacy into Large Tabular Models and Myelin for persistent AI-agent context, with the website citing 4.2B tokens of agent work per day internally. This breadth signals ongoing product development and ambition across the enterprise AI stack.

Strategic Partnerships: Participation in Google Cloud Partner Advantage and availability on AWS and Google Cloud marketplaces enhance enterprise procurement and distribution pathways. These moves indicate progress in market access even if customer counts remain undisclosed.

Strong Revenue Growth: Revenue has risen consistently, with annual growth in the high single digits and the latest quarter showing double-digit year-over-year increases, and management raising full-year growth guidance. Organic constant-currency expansion in the latest quarter indicates underlying momentum beyond acquisitions and FX.

Profitability: Profitability is improving alongside sales, as net income and adjusted diluted EPS increased year over year in the latest quarter. Full-year results also showed higher net income and adjusted EBITDA.

Market Expansion: Growth appears across U.S. Markets and internationally, with U.S. Financial Services leading and international results positive on an organic constant-currency basis. The company is extending its reach through moves such as acquiring a majority stake in Trans Union de México.

Market Expansion: Evidence indicates the 2026 acquisition of Urgently and added commercial roles broaden Agero’s reach across automotive, fleet, rental, and insurance, taking the combined platform to about 150 million vehicles and roughly 13–14 million annual service events. New and renewed programs further extend activity across roadside assistance, claims, and mobility services.

Strong Market Position & Advantage: Company materials describe service to approximately 150 million drivers, relationships with six of the top ten insurers, and a nationwide network of 8,000+ providers. External recognition such as Frost & Sullivan’s 2025 North American Company of the Year reinforces a durable competitive position in digitalized roadside assistance.

Strategic Partnerships: Renewals and wins like Hagerty and Virginia Farm Bureau Insurance, plus collaborations such as MOTER, point to deep, ongoing enterprise relationships. These ties support recurring service volumes and cross-sell opportunities across roadside, accident management, and connected-vehicle offerings.

Strong Revenue Growth: Revenue is accelerating, with Q2 2026 rising 22% year over year to $98.7 million and first-half 2026 up about 14%, while management raised full-year revenue guidance to $400–$410 million. This momentum follows relatively modest 2025 growth, indicating a notable reacceleration in 2026.

Healthy Cash Flow: Cash generation improved, with Q2 2026 free cash flow of $12.9 million versus $5.3 million a year earlier and stronger operating leverage reflected in higher adjusted EBITDA. This suggests the business is converting growth into better cash performance even as GAAP profitability remains mixed.

Market Expansion: Business activity is broadening, with Q2 2026 GMV up 13% year over year to $41.3 billion, new merchant wins across all four regions, and expansion into additional payment types like ACH. Rising GMV alongside revenue indicates growth supported by increased platform usage, not just pricing.

Strong Revenue Growth: Revenue is reported to have increased from about $69M in 2024 to $101M in 2025, with an annualized run rate later exceeding $125–$130M. This trajectory indicates accelerating top-line momentum following a prior slowdown.

Profitability: The company is described as achieving its first annual profit, with figures citing approximately $3M net income in 2025. This inflection coincides with revenue gains and signals improved operating performance.

Market Expansion: State coverage is said to have expanded by 19 new launches in 2025, bringing availability to roughly 33–34 states. Broader geographic reach alongside launches like Possible Advance expands the addressable market.

Strong Revenue Growth: Annual recurring revenue increased 12% in 2023, alongside 43% growth in higher-margin recurring services. While historical, these figures indicate expansion in the recurring business model.

Innovation-Driven Growth: Vendavo AI was launched in 2025 with further AI and machine-learning enhancements announced in 2026, embedding intelligence across pricing, quoting, and rebate workflows. These investments point to continued product development intended to expand the platform’s value.

Market Expansion: In July 2026 the company announced an agreement to acquire Model N’s High-Tech business unit and introduced a High-Tech Revenue Management solution targeting semiconductor and high-tech manufacturing. These moves suggest efforts to broaden industry reach through acquisitions and new offerings.

Innovation-Driven Growth: Product expansion beyond shipment tracking into AI agents, inventory intelligence, automated ocean freight booking, and an Outcome-as-a-Service model reflects continued investment in new capabilities. These launches aim to deliver measurable operational results and deepen the platform’s role in supply-chain automation.

Strong Market Position & Advantage: Industry recognition such as a 2024 Leader placement in Gartner’s Real-Time Transportation Visibility Platforms and a 2026 Leader placement in Nucleus Research’s Control Tower matrix, alongside scale serving 1,600+ brands and millions of daily shipments, points to a durable competitive position. These signals indicate established enterprise adoption and credibility in core markets.

Strong Revenue Growth: The Indian subsidiary reported revenue rising from ₹124.4 crore in FY2024 to ₹147.4 crore in FY2025, evidencing tangible top-line expansion within that operation. While not a consolidated global view, this datapoint supports momentum in at least one major entity.

Strong Revenue Growth: Reported annual recurring subscription and service revenue grew by more than 220% in 2025, resulting in ARR more than tripling. The increase is attributed to new and expanding relationships with private‑equity sponsors and their portfolio companies.

Market Expansion: Sponsor partnerships are described as having doubled, broadening commercial reach across private‑equity networks. The company also scaled geographically, adding offices in locations such as Chicago, New York, Toronto, Dallas, and Bengaluru.

Product Line Growth: New offerings include the Astradis platform, an AI‑powered pricing suite, expanded healthcare functionality, and the launch of Astra Labs. These additions broaden the addressable market and signal continued investment in AI‑driven solutions.

Strong Revenue Growth: Company-reported metrics indicate revenue increased tenfold over four years and bookings rose 10× over three years. Nearly fivefold headcount growth over a similar period reinforces that the business scaled operating capacity alongside top-line gains.

Investor Backing & Capital Strength: A $100 million investment from Blackstone Growth in January 2026, with reporting of an approximately $700 million valuation, signals substantial capital support. This financing is described as fuel for technology development and broader customer expansion.

Diversified Customer Base: The platform is described as serving more than 100 Fortune 500 companies as well as major agencies, trade associations, nonprofits, and advocacy groups. This spread indicates exposure across multiple enterprise and institutional segments rather than dependence on a narrow set of buyers.

Strong Revenue Growth: Revenue is rising steadily, including 11% year-over-year growth to $192.8 million in Q2 2026 and 7% growth for full-year 2025. The step-up from 6% growth in Q1 2026 to 11% in Q2 indicates accelerating momentum.

Profitability: Adjusted EBITDA increased 30% year over year in Q2 2026 as margin expanded from 34% to 37%, signaling operating leverage. Net income also improved to $19.4 million from $11.1 million year over year in that quarter.

Healthy Cash Flow: Guidance points to free-cash-flow growth in the high-40% range for 2026 alongside adjusted EBITDA growth of more than 20%. Operating cash flow reached $57.4 million in Q2 2026.

Investor Backing & Capital Strength: Recent financing momentum is evident, with a $70M Series C in May 2025 led by Avra and participation from firms such as Andreessen Horowitz, Sequoia, Redpoint, and Snowflake Ventures. This capital is positioned to support further product and go-to-market expansion while signaling confidence in the company’s trajectory.

Market Expansion: Customer adoption appears to be broadening from more than 1,500 teams in May 2025 to more than 2,000 customers globally, including enterprises like Reddit, Figma, HubSpot, Rivian, and Anthropic. Evidence of scaling usage, such as hundreds of millions of usage-based billing events and increased adoption of advanced compute add-ons, reinforces this expansion.

Innovation-Driven Growth: Product momentum centers on AI-powered analytics and agentic workflows, including features like the Notebook Agent and moves into embedded analytics. The acquisition of Hashboard and introduction of usage-based monetization for advanced compute suggest continued innovation aligned with market shifts.